Farther Finance Advisors’s Cidara Therapeutics CDTX Stock Holding History

Farther Finance Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19	Closed	-$4.2K	–	5778
2025 Q4	$4.2K	Buy	19 +14	+280%	+$2.26K	﹤0.01%	4398
2025 Q3	$479	Buy	+5	New	+$319	﹤0.01%	4552

Farther Finance Advisors's CDTX Position: Q1 2026 in Review

Farther Finance Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 19 shares — an estimated $4.2K sold.

Farther Finance Advisors first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $4.2K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Farther Finance Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Farther Finance Advisors sold 19 Cidara Therapeutics shares in Q1 2026, an estimated $4.2K.
Farther Finance Advisors first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Farther Finance Advisors's Cidara Therapeutics position peaked at $4.2K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.